tiprankstipranks

Charles Theuer Insider Profile

102 Followers
Charles Theuer, President & CEO, Director at TRACON Pharmaceuticals, holds 406.42K shares in TRACON Pharmaceuticals (Ticker: TCON), holds 14.68K shares in Oncternal Therapeutics (Ticker: ONCT), holds ― shares in 4D Molecular Therapeutics (Ticker: FDMT).
tipranks
Charles Theuer

Charles Theuer
TRACON Pharmaceuticals (TCON)
President & CEO, Director

Ranked #801 out of 97,997 Corporate Insiders

Profitable Transactions

30%
10 out of 33 Profitable Transactions

Average Return

+38.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$360K
70.23%
29.77%
0.00%
A breakdown of Charles Theuer's holdings

Insider Roles

TRACON Pharmaceuticals
(TCON)
President & CEO, Director
Oncternal Therapeutics
(ONCT)
Director
4D Molecular Therapeutics
(FDMT)
Director
Roles that Charles Theuer holds in companies

Most Profitable Insider Trade

Stock:
TRACON Pharmaceuticals
(TCON)
Rating:Informative Buy
Date:Mar 13, 2020 - Mar 13, 2021
Return:+750.40%
The most profitable trade made by Charles Theuer

Charles Theuer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TRACON Pharmaceuticals
Mar 13, 2024
President & CEO, Director
Uninformative Buy
910.00
$252.79K
Oncternal Therapeutics
Jun 11, 2019
Director
Uninformative Buy
$107.14K
4D Molecular Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Charles Theuer's performance on stock

Charles Theuer insider profile FAQ

What is the percentage of profitable transactions made by Charles Theuer?
The percentage of profitable transactions made by Charles Theuer is 30%.
    What is the average return per transaction made by Charles Theuer?
    The average return per transaction made by Charles Theuer is 38.60%.
      What stocks does Charles Theuer hold?
      Charles Theuer holds: TCON, ONCT, FDMT stocks.
        What was Charles Theuer’s latest transaction?
        Charles Theuer latest transaction was an Uninformative Buy of $910.00.
          What was Charles Theuer's most profitable transaction?
          Charles Theuer’s most profitable transaction was an Informative Buy of TCON stock on March 13, 2020. The return on the trade was 750.40%.
            What is Charles Theuer's role in TRACON Pharmaceuticals?
            Charles Theuer's role in TRACON Pharmaceuticals is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.